Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association.
Maron BJ, Thompson PD, Puffer JC, McGrew CA, Strong WB, Douglas PS, Clark LT, Mitten MJ, Crawford MH, Atkins DL, Driscoll DJ, Epstein AE. Maron BJ, et al. Among authors: clark lt. Circulation. 1996 Aug 15;94(4):850-6. doi: 10.1161/01.cir.94.4.850. Circulation. 1996. PMID: 8772711 No abstract available.
Cardiovascular preparticipation screening of competitive athletes: addendum: an addendum to a statement for health professionals from the Sudden Death Committee (Council on Clinical Cardiology) and the Congenital Cardiac Defects Committee (Council on Cardiovascular Disease in the Young), American Heart Association.
Maron BJ, Thompson PD, Puffer JC, McGrew CA, Strong WB, Douglas PS, Clark LT, Mitten MJ, Crawford MD, Atkins DL, Driscoll DJ, Epstein AE. Maron BJ, et al. Among authors: clark lt. Circulation. 1998 Jun 9;97(22):2294. doi: 10.1161/01.cir.97.22.2294. Circulation. 1998. PMID: 9631885 No abstract available.
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III.
Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT, Criqui MH, Crouse JR 3rd, Friedman L, Fuster V, Herrington DM, Kuller LH, Ridker PM, Roberts WC, Stanford W, Stone N, Swan HJ, Taubert KA, Wexler L. Greenland P, et al. Among authors: clark lt. Circulation. 2000 Jan 4;101(1):E16-22. doi: 10.1161/01.cir.101.1.e16. Circulation. 2000. PMID: 10618318 No abstract available.
Enhancing Diversity and Inclusion in Clinical Trials.
Corneli A, Hanlen-Rosado E, McKenna K, Araojo R, Corbett D, Vasisht K, Siddiqi B, Johnson T, Clark LT, Calvert SB. Corneli A, et al. Among authors: clark lt. Clin Pharmacol Ther. 2023 Mar;113(3):489-499. doi: 10.1002/cpt.2819. Epub 2023 Jan 11. Clin Pharmacol Ther. 2023. PMID: 36628990 Review.
COVID-19 inpatient cohorting team: Successes and lessons learned.
Clark LTS, Sanchez S, Phelan C, Sokol-Hessner L, Bruce K, DeSanto-Madeya S. Clark LTS, et al. Nurs Manage. 2021 May 1;52(5):38-45. doi: 10.1097/01.NUMA.0000737624.29748.4e. Nurs Manage. 2021. PMID: 33908921 No abstract available.
105 results